Cases 101 - 110 of 917
WALKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv01372
Plaintiff:
SHELDON WALKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DARABARIS v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01048
Plaintiff:
JEREMY DARABARIS
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALLAGHER v. HETERO DRUGS, LTD. et al
as 1:2022cv00930
Plaintiff:
KELLY GALLAGHER
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, HETERO DRUGS, LTD., HETERO LABS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
TIPPETT et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00826
Plaintiff:
GARY LEE TIPPETT and ADELLA TIPPETT
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CASTEEL v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00800
Plaintiff:
JOE CASTEEL
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BRANCH v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00582
Plaintiff:
TERRELL BRANCH
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
KRUG et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00194
Plaintiff:
Elizabeth Krug and Kevin Krug
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., JOHN DOE and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KAPLAN v. MYLAN N.V. et al
as 1:2021cv20159
Plaintiff:
WILLIAM KAPLAN
Defendant:
MYLAN N.V., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
